2,610 Shares in Danaher Corporation $DHR Acquired by NewEdge Wealth LLC

NewEdge Wealth LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel.com reports. The fund bought 2,610 shares of the conglomerate’s stock, valued at approximately $1,879,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DHR. Northwestern Mutual Wealth Management Co. increased its position in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Legal & General Group Plc raised its position in Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares during the period. Handelsbanken Fonder AB raised its holdings in shares of Danaher by 10.9% in the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after buying an additional 28,425 shares during the period. Advisors Capital Management LLC lifted its position in shares of Danaher by 14.0% during the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares in the last quarter. Finally, Swiss Life Asset Management Ltd lifted its holdings in Danaher by 12.1% during the 4th quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock worth $26,402,000 after buying an additional 12,416 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 2.2%

DHR opened at $216.14 on Friday. The stock has a market capitalization of $151.94 billion, a P/E ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The business has a 50 day simple moving average of $195.01 and a 200-day simple moving average of $192.43. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm posted $0.77 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. On average, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on DHR. TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Argus reduced their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Finally, Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.